Analyst Ratings for Myriad Genetics (mygn)
mygn Rating Summary
mygn Price Target Summary
- Highest: $10.00 (Craig-Hallum)
- Lowest: $3.00 (Stephens)
- Average: $5.53
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$5.53 (+71.7%)
* Over Last 12-Mos
Rating Score: 2.3 / 10
Percentile Rank: 18%
Rating Score: 2.3 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2025 | Scotiabank | Sung Ji Nam | Downgrade | Sector Perform (Sector Outperform) |
6.00 (20.00) |
4.43 (3.22) |
-27.31% | Details |
| 5/8/2025 | Wolfe Research | Doug Schenkel | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
7.27 (3.22) |
-55.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
